|
ACTR8 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.238800E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.406400E-01 |
| Normal-vs-Stage2 |
6.725800E-01 |
| Normal-vs-Stage3 |
4.384800E-01 |
| Normal-vs-Stage4 |
1.71878999999375E-05 |
| Stage1-vs-Stage2 |
8.633800E-01 |
| Stage1-vs-Stage3 |
2.508800E-01 |
| Stage1-vs-Stage4 |
3.786500E-04 |
| Stage2-vs-Stage3 |
3.860800E-01 |
| Stage2-vs-Stage4 |
6.702400E-03 |
| Stage3-vs-Stage4 |
3.848200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.354000E-01 |
| Normal-vs-AfricanAmerican |
5.190200E-01 |
| Normal-vs-Asian |
2.160600E-01 |
| Caucasian-vs-AfricanAmerican |
7.450200E-01 |
| Caucasian-vs-Asian |
2.852400E-01 |
| AfricanAmerican-vs-Asian |
2.455400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.854400E-01 |
| Normal-vs-Female |
3.648100E-02 |
| Male-vs-Female |
1.651870E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.521400E-01 |
| Normal-vs-Extreme_Weight |
8.854300E-02 |
| Normal-vs-Obese |
3.633200E-01 |
| Normal-vs-Extreme_Obese |
4.476600E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.834000E-01 |
| Normal_Weight-vs-Obese |
2.440600E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.685600E-01 |
| Extreme_Weight-vs-Obese |
3.208200E-02 |
| Extreme_Weight-vs-Extreme_Obese |
2.314000E-01 |
| Obese-vs-Extreme_Obese |
5.863600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.633200E-01 |
| Normal-vs-Age(41-60Yrs) |
3.055600E-01 |
| Normal-vs-Age(61-80Yrs) |
9.709000E-01 |
| Normal-vs-Age(81-100Yrs) |
9.891600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.147600E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.804600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.176600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.736400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.856000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.799000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.768400E-01 |
| Normal-VS-Type2 PRCC |
7.074800E-01 |
| Normal-VS-KIRP CIMP |
4.38620000000611E-05 |
| Normal-VS-Unclassified PRCC |
1.762800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.909200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.79108999999178E-05 |
| Type1 PRCC-VS-Unclassified PRCC |
3.401800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.715800E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
1.146580E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.218370E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.320000E-01 |
| Normal-vs-N1 |
1.573160E-01 |
| Normal-vs-N2 |
6.3656000000023E-05 |
| N0-vs-N1 |
7.530400E-01 |
| N0-vs-N2 |
1.883810E-01 |
| N1-vs-N2 |
1.682640E-01 |
|
|
